In this episode, Dr. Mahnia Madan and I discuss the challenges of managing glaucoma and dry eye conditions. We explore the impact of glaucoma medications on dry eyes, the importance of tailored treatment plans, cyclosporines, lid hygiene, in-office therapies like IPL, and the collaborative approach between optometrists and ophthalmologists. The discussion emphasizes the need for personalized care to improve patients' quality of life.
All content for Talking About Glaucoma (AAC) is the property of Robert M Schertzer, MD, MEd, FRCSC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, Dr. Mahnia Madan and I discuss the challenges of managing glaucoma and dry eye conditions. We explore the impact of glaucoma medications on dry eyes, the importance of tailored treatment plans, cyclosporines, lid hygiene, in-office therapies like IPL, and the collaborative approach between optometrists and ophthalmologists. The discussion emphasizes the need for personalized care to improve patients' quality of life.
Ep 27 Talking About Glaucoma - 1Mar2017: Harbin Ethics in Medical Tx (AAC Enhanced)
Talking About Glaucoma (AAC)
16 minutes 29 seconds
8 years ago
Ep 27 Talking About Glaucoma - 1Mar2017: Harbin Ethics in Medical Tx (AAC Enhanced)
In this episode, Tom Harbin, from Eye Consultants of Atlanta, and I discuss ethical issues in the medical treatment of glaucoma. This includes generic vs brand name drugs, the need to shop around for the best price, and looking out for talks from so-called Key Opinion Leaders.
Talking About Glaucoma (AAC)
In this episode, Dr. Mahnia Madan and I discuss the challenges of managing glaucoma and dry eye conditions. We explore the impact of glaucoma medications on dry eyes, the importance of tailored treatment plans, cyclosporines, lid hygiene, in-office therapies like IPL, and the collaborative approach between optometrists and ophthalmologists. The discussion emphasizes the need for personalized care to improve patients' quality of life.
